ARCHIVES

Varmus: Why are scientific societies obstructing public access to research results?

This article is from The Cancer Letter archive.

Vol. 31 No. 20 | May 20, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

August 7, 2009

In Brief: Lippman Leads M.D. Anderson Clinical Prevention; Baylin Named Ludwig Professor

May 10, 1996

First Phase 0 Oncology Trial Demonstrates Effectiveness Of New Drug On Its Target

April 24, 2009

Lame Duck NCI Director: Cancer Centers Should Run Cancer Clinical Trials System

June 25, 2010

Funding Opportunities: NIH Creates Awards For Clinical Research

March 27, 1998

R01 Grants Pool, New Investigators Hit By Budget Strains

October 27, 1989